Ultralife (NASDAQ:ULBI) reported second-quarter 2026 revenue of $47.9 million, operating income of $3.4 million and diluted earnings per share of $0.15, as the company cited stronger gross margins, a record backlog and continued investment in product development across its battery and communications
$ULBI
Price history, market instrument context, member research, and related headlines in one place.
ULBI key statistics
NasdaqGMUSD
52-week range
$4.9036%$8.25
Latest session $5.94–$6.29Ultralife Corporation (ULBI) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $6.11, up $0.06 (0.99%) from the previous close of $6.05. It has traded between $5.94 and $6.29 in the latest session. Over the past year it has ranged from $4.90 to $8.25, leaving it in the lower half of its 52-week range (36%). Reported volume for the session was 19.8K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $ULBI research…